Last updated: 26 August 2024 at 4:33pm EST

Evan Bakst Net Worth




The estimated Net Worth of Evan Bakst is at least $506 Tysiąc dollars as of 23 August 2024. Mr. Bakst owns over 35,000 units of Alphatec Inc stock worth over $272,500 and over the last 6 years he sold ATEC stock worth over $129,804. In addition, he makes $104,036 as Independent Director at Alphatec Inc.

Mr. Bakst ATEC stock SEC Form 4 insiders trading

Evan has made over 5 trades of the Alphatec Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 35,000 units of ATEC stock worth $201,600 on 23 August 2024.

The largest trade he's ever made was buying 35,000 units of Alphatec Inc stock on 23 August 2024 worth over $201,600. On average, Evan trades about 7,439 units every 166 days since 2018. As of 23 August 2024 he still owns at least 50,000 units of Alphatec Inc stock.

You can see the complete history of Mr. Bakst stock trades at the bottom of the page.





Evan Bakst biography

Evan Bakst is Independent Director of the Company. Mr. Bakst is the Founder and Portfolio Manager of Treetop Capital since 2013, a fundamental, value-oriented investment firm focused primarily on small to midcap healthcare companies. Before launching Treetop, Mr. Bakst spent seven years (2005-2012) at Tremblant Capital, a long/short equity hedge fund, most recently as a Partner where he led the healthcare group. Prior to joining Tremblant, Mr. Bakst was a Principal at JPMorgan Partners, LLC (2000-2005), where he shared the day-to-day responsibility for managing the healthcare buyout practice. Previously, Mr. Bakst was a Managing Director at The Beacon Group, a private equity/M&A boutique and, prior to that, Mr. Bakst worked as a Consultant at Bain and Company, providing strategic and operational advice to a major healthcare company. Mr. Bakst is currently on the Board of Sonacare Medical, LLC, and was formerly on the Boards of Accordant Health Services, Cadent Holdings, Inc., FundsXpress Inc., Iasis Healthcare, MedQuest Associates, National Surgical Care, Quality Tubing Inc. and ValueOptions. Mr. Bakst earned a B.A. in Economics from the University of California, Berkeley, and an M.B.A. from the Harvard Business School.

What is the salary of Evan Bakst?

As the Independent Director of Alphatec Inc, the total compensation of Evan Bakst at Alphatec Inc is $104,036. There are 13 executives at Alphatec Inc getting paid more, with Patrick Miles having the highest compensation of $7,960,100.



How old is Evan Bakst?

Evan Bakst is 53, he's been the Independent Director of Alphatec Inc since 2018. There are 10 older and 14 younger executives at Alphatec Inc. The oldest executive at Alphatec Holdings Inc is Ward Woods, 77, who is the Independent Director.

What's Evan Bakst's mailing address?

Evan's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.

Insiders trading at Alphatec Inc

Over the last 18 years, insiders at Alphatec Inc have traded over $1,216,108,242 worth of Alphatec Inc stock and bought 24,460,197 units worth $141,338,962 . The most active insiders traders include Mortimer Iii Berkowitz, John Foster oraz Llc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of $1,610,824. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth $201,600.



What does Alphatec Inc do?

as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com



Complete history of Mr. Bakst stock trades at Alphatec Inc

Osoba
Trans.
Transakcja
Łączna cena
Evan Bakst
Kupować $201,600
23 Aug 2024
Evan Bakst
Kupować $202,950
14 Mar 2024
Evan Bakst
Sprzedaż $129,804
23 Aug 2023
Evan Bakst
Kupować $105,700
26 Nov 2021
Evan Bakst
Kupować $53,266
11 Mar 2019


Alphatec Inc executives and stock owners

Alphatec Inc executives and other stock owners filed with the SEC include: